Literature DB >> 6260668

Dimethyl sulfoxide inhibits killing of Staphylococcus aureus by polymorphonuclear leukocytes.

J E Repine, R B Fox, E M Berger.   

Abstract

Increasing concentrations of the highly permeable, hydroxyl radical scavenger dimethyl sulfoxide progressively decreased killing of Staphylococcus aureus 502A by human polymorphonuclear leukocytes; methane, a product of the reaction of the hydroxyl radical with dimethyl sulfoxide, was generated in the process.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6260668      PMCID： PMC351813          DOI： 10.1128/iai.31.1.510-513.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  19 in total

1.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Quantitation of maximal bactericidal capability in human neutrophils.

Authors:  C C Clawson; J E Repine
Journal:  J Lab Clin Med       Date:  1976-08

3.  Defective superoxide production by granulocytes from patients with chronic granulomatous disease.

Authors:  J T Curnutte; D M Whitten; B M Babior
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

4.  Absorption, distribution and elimination of labeled dimethyl sulfoxide in man and animals.

Authors:  K H Kolb; G Jaenicke; M Kramer; P E Schulze
Journal:  Ann N Y Acad Sci       Date:  1967-03-15       Impact factor: 5.691

5.  The comparative penetrant-carrier action of dimethyl sulfoxide and ethyl alcohol in vivo.

Authors:  P N Narula
Journal:  Ann N Y Acad Sci       Date:  1967-03-15       Impact factor: 5.691

6.  Biological implications of DMSO based on a review of its chemical properties.

Authors:  D H Rammler; A Zaffaroni
Journal:  Ann N Y Acad Sci       Date:  1967-03-15       Impact factor: 5.691

7.  Biological defense mechanisms. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase.

Authors:  B M Babior; J T Curnutte; R S Kipnes
Journal:  J Lab Clin Med       Date:  1975-02

8.  Oxygen metabolism in Lactobacillus plantarum.

Authors:  E M Gregory; I Fridovich
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

9.  Singlet excited oxygen as a mediator of the antibacterial action of leukocytes.

Authors:  N I Krinsky
Journal:  Science       Date:  1974-10-25       Impact factor: 47.728

10.  Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease.

Authors:  J E Repine; J G White; C C Clawson; B M Holmes
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808
View more
  5 in total

1.  Thiourea and dimethylthiourea decrease human neutrophil bactericidal function in vitro.

Authors:  J H Jackson; E M Berger; J E Repine
Journal:  Inflammation       Date:  1988-10       Impact factor: 4.092

2.  Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils.

Authors:  N Okamura; J K Spitznagel
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

3.  Effect of dimethyl sulfoxide on the in vitro and in vivo bactericidal activity of human and mouse neutrophils and mononuclear phagocytes.

Authors:  C J Czuprynski; P M Henson; P A Campbell
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

4.  Dimethyl sulfoxide inhibits phagocyte influx into infected pleural spaces and phagocyte locomotion in vitro.

Authors:  V B Antony; S A Sahn; J E Repine
Journal:  Inflammation       Date:  1983-12       Impact factor: 4.092

5.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Authors:  L A Smedly; M G Tonnesen; R A Sandhaus; C Haslett; L A Guthrie; R B Johnston; P M Henson; G S Worthen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.